Search PDMR transactions

Notifier
Name of person with notification obligation
RENÉE AGUIAR LUCANDER
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
RENÉE AGUIAR LUCANDER
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Calliditas Therapeutics AB
Issuer´s LEI code
549300PVPZO8TNT76B58
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subcription warrant Calliditas Therapeutics AB Exercise decrease 175,000 Quantity 0.00 SEK 24/03/2022 Outside a trading venue
Share Calliditas Therapeutics AB SE0010441584 Exercise increase 175,000 Quantity 74.30 SEK 24/03/2022 Outside a trading venue
Subcription warrant Calliditas Therapeutics AB Disposal 175,000 Quantity 6.30 SEK 22/03/2022 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Calliditas Therapeutics AB Exercise decrease 24/03/2022 Outside a trading venue 175,000 (Quantity) 0.00 SEK
Calliditas Therapeutics AB SE0010441584 Exercise increase 24/03/2022 Outside a trading venue 175,000 (Quantity) 74.30 SEK
Calliditas Therapeutics AB Disposal 22/03/2022 Outside a trading venue 175,000 (Quantity) 6.30 SEK
<< Back